thiophenes has been researched along with fibrin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Beller, FK; Slabber, CF; Theiss, W | 1 |
| Blasi, F; Hanemaaijer, R; Koolwijk, P; Peters, E; Sidenius, N; Sier, CF; van Hinsbergh, VW | 1 |
| Collen, A; Grimbergen, J; Hanemaaijer, R; Koolwijk, P; Lupu, F; Peters, E; Quax, PH; van Hinsbergh, VW; van Lent, N | 1 |
| Nebieridze, DV; Oganov, RG | 1 |
| Chidiac, J; Jamshedov, J; Klein, C; Mirshahi, M; Mirshahi, P; Mirshahi, S; Perzborn, E; Soria, C; Soria, J; Varin, R | 1 |
| Hosokawa, K; Koide, T; Maruyama, I; Miura, N; Ohnishi, T; Sameshima, H; Tanaka, KA | 1 |
| Alemán, C; Armelin, E; del Valle, LJ; Estrany, F; Fabregat, G; Teixeira-Dias, B | 1 |
| Altomare, CD; Belviso, BD; Caliandro, R; Colucci, M; de Candia, M; Incampo, F; Lopopolo, G; Zaetta, G | 1 |
| Alemán, C; Armelin, E; Del Valle, LJ; Puiggalí-Jou, A | 1 |
| Fujiwara, Y; Jo, JI; Saito, Y; Tabata, Y; Tanaka, R | 1 |
| Bicknell, AB; Lakshminarayanan, K; Layfield, HJ; Mehmi, A; Patel, K; Ravishankar, D; Salim, A; Sonavane, M; Trim, SA; Vaiyapuri, R; Vaiyapuri, S; Vallance, TM; Williams, HF | 1 |
1 trial(s) available for thiophenes and fibrin
| Article | Year |
|---|---|
[Metabolic effects of angiotensin-II receptor blockers].
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cholesterol; Endothelium, Vascular; Fibrin; Humans; Hypertension; Imidazoles; Male; Receptors, Angiotensin; Thiophenes | 2002 |
10 other study(ies) available for thiophenes and fibrin
| Article | Year |
|---|---|
The prevention of endotoxin-induced glomerular fibrin deposition by pyrimido-pyrimidine compounds.
Topics: Animals; Aspirin; Blood Cell Count; Blood Platelets; Disseminated Intravascular Coagulation; Endotoxins; Escherichia coli; Female; Fibrin; Fibrinogen; Injections, Intravenous; Kidney Glomerulus; Microcirculation; Morpholines; Pyrimidines; Rabbits; Thiophenes | 1972 |
Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices.
Topics: Binding Sites; Blotting, Western; Cells, Cultured; Endothelium, Vascular; Fibrin; Fibroblast Growth Factor 2; Gene Expression; Humans; Metalloendopeptidases; Microcirculation; Neovascularization, Physiologic; Phenylalanine; Protease Inhibitors; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiophenes; Transfection; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator | 2001 |
Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.
Topics: Adenoviridae; Aprotinin; Cells, Cultured; Collagen; Culture Media; Defective Viruses; Drug Synergism; Endothelial Growth Factors; Endothelium, Vascular; Fibrin; Fibroblast Growth Factor 2; Genetic Vectors; Heart Diseases; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Neovascularization, Pathologic; Neovascularization, Physiologic; Phenylalanine; Protease Inhibitors; Thiophenes; Thrombosis; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-3; Transduction, Genetic; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
Topics: Anticoagulants; Blood; Blood Coagulation; Blood Platelets; Erythrocytes; Factor XIII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Morpholines; Permeability; Plasma; Risk Factors; Rivaroxaban; Thiophenes; Thrombin; Thrombolytic Therapy; Thromboplastin; Thrombosis; Time Factors | 2013 |
Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model.
Topics: Adenosine Triphosphate; Adult; Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Blood Platelets; Dabigatran; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Female; Fibrin; Humans; Lab-On-A-Chip Devices; Male; Microscopy, Confocal; Morpholines; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rivaroxaban; Thiophenes; Thrombin; Thromboplastin; Thrombosis | 2014 |
Incorporation of a clot-binding peptide into polythiophene: properties of composites for biomedical applications.
Topics: Animals; Biocompatible Materials; Blood Coagulation; Blood Proteins; Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Electrochemistry; Fibrin; Humans; Hydrogen-Ion Concentration; Materials Testing; Mice; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Peptides; Photoelectron Spectroscopy; Polymers; Thiophenes; Water | 2014 |
How a β-D-glucoside side chain enhances binding affinity to thrombin of inhibitors bearing 2-chlorothiophene as P1 moiety: crystallography, fragment deconstruction study, and evaluation of antithrombotic properties.
Topics: Anticoagulants; Antithrombins; Binding Sites; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrin; Fibrinolysis; Glucosides; Humans; Hydrogen Bonding; Models, Molecular; Structure-Activity Relationship; Thiophenes; Thrombin | 2014 |
Fibrin Association at Hybrid Biointerfaces Made of Clot-Binding Peptides and Polythiophene.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion; Coated Materials, Biocompatible; Female; Fibrin; Humans; Male; MCF-7 Cells; Membranes, Artificial; Neoplasm Metastasis; Oligopeptides; Polymers; Thiophenes; Thrombin | 2016 |
Preparation of fibrin hydrogels to promote the recruitment of anti-inflammatory macrophages.
Topics: Animals; Antigens, CD; Fibrin; Gene Expression Regulation; Hydrogels; Inflammation; Interleukin-10; Macrophages; Male; Mice; Oxadiazoles; Thiophenes; Tumor Necrosis Factor-alpha | 2019 |
Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake,
Topics: Animals; Antineoplastic Agents; Antivenins; Binding Sites; Blood Platelets; Catalytic Domain; Collagen; Crotalid Venoms; Crotalus; Drug Repositioning; Erythrocytes; Fibrin; Fibrinolysis; Hemolysis; Humans; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Molecular Docking Simulation; Phenylalanine; Protein Binding; Protein Conformation; Structure-Activity Relationship; Substrate Specificity; Thiophenes | 2020 |